Title : Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.

Pub. Date : 2012 Jun

PMID : 21607553






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tolvaptan, an oral, selective arginine vasopressin (AVP) V2 receptor antagonist has been approved for the treatment of euvolemic and hypervolemic hyponatremia in the United States. Tolvaptan arginine vasopressin Homo sapiens